Gene · 406957
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. | Int J Mol Sci | 2023 | 38003230 | PubTator, text mining | PubMed |
| The Role of Exosome-Derived microRNA on Lung Cancer Metastasis Progression. | Biomolecules | 2023 | 38002256 | PubTator, text mining | PubMed |
| Circular RNAs: A New Approach to Multiple Sclerosis. | Biomedicines | 2023 | 38001884 | PubTator, text mining | PubMed |
| Current Knowledge about the Peritumoral Microenvironment in Glioblastoma. | Cancers (Basel) | 2023 | 38001721 | PubTator, text mining | PubMed |
| Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 37986299 | PubTator, text mining | PubMed |
| The Levels of Leptin, Cystatin C, Neuropilin-1 and Tau Protein in Relation to Dietary Habits in Patients with Alzheimer's Disease. | J Clin Med | 2023 | 37959320 | PubTator, text mining | PubMed |
| Exosomes Interactions with the Blood-Brain Barrier: Implications for Cerebral Disorders and Therapeutics. | Int J Mol Sci | 2023 | 37958619 | PubTator, text mining | PubMed |
| MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer. | Cell Biosci | 2023 | 37932806 | PubTator, text mining | PubMed |
| Small RNAs, spermatogenesis, and male infertility: a decade of retrospect. | Reprod Biol Endocrinol | 2023 | 37924131 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Post-Traumatic Epileptogenesis: A Systematic Review. | Int J Mol Sci | 2023 | 37895044 | PubTator, text mining | PubMed |
| Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management. | Cancers (Basel) | 2023 | 37894470 | PubTator, text mining | PubMed |
| Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine. | Biomedicines | 2023 | 37893238 | PubTator, text mining | PubMed |
| Engineered Vesicles and Hydrogel Technologies for Myocardial Regeneration. | Gels | 2023 | 37888397 | PubTator, text mining | PubMed |
| MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens. | Biology (Basel) | 2023 | 37887044 | PubTator, text mining | PubMed |
| Validation of a Novel Cuproptosis-Related Prognostic Gene Marker and Differential Expression Associated with Lung Adenocarcinoma. | Curr Issues Mol Biol | 2023 | 37886979 | PubTator, text mining | PubMed |
| Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis. | Front Mol Neurosci | 2023 | 37881368 | PubTator, text mining | PubMed |
| Role of osteopontin in cancer development and treatment. | Heliyon | 2023 | 37867833 | PubTator, text mining | PubMed |
| Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis. | Medicine (Baltimore) | 2023 | 37861500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406957/papers?page=5